Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-8,595
Closed -$537K 343
2025
Q4
$537K Sell
8,595
-3,147
-27% -$179K 0.02% 204
2025
Q3
$556K Hold
11,742
0.02% 191
2025
Q2
$515K Hold
11,742
0.02% 191
2025
Q1
$376K Hold
11,742
0.01% 215
2024
Q4
$345K Sell
11,742
-896
-7% -$27.2K 0.01% 223
2024
Q3
$367K Hold
12,638
0.01% 212
2024
Q2
$475K Hold
12,638
0.02% 193
2024
Q1
$559K Hold
12,638
0.02% 185
2023
Q4
$437K Sell
12,638
-20,410
-62% -$552K 0.02% 201
2023
Q3
$838K Hold
33,048
0.04% 149
2023
Q2
$915K Hold
33,048
0.05% 140
2023
Q1
$651K Hold
33,048
0.03% 160
2022
Q4
$705K Sell
33,048
-4,550
-12% -$103K 0.04% 152
2022
Q3
$831K Hold
37,598
0.04% 130
2022
Q2
$792K Hold
37,598
0.04% 138
2022
Q1
$1.01M Hold
37,598
0.06% 129
2021
Q4
$1.12M Hold
37,598
0.06% 125
2021
Q3
$1.26M Buy
37,598
+13,983
+59% +$561K 0.07% 104
2021
Q2
$1.07M Sell
23,615
-10,745
-31% -$484K 0.06% 111
2021
Q1
$1.52M Buy
34,360
+22,274
+184% +$1.28M 0.1% 78
2020
Q4
$759K Buy
+12,086
New +$842K 0.05% 120

Other funds holding FROG

Aspiriant LLC's FROG Position: Q1 2026 in Review

Aspiriant LLC sold out of JFrog (FROG) in Q1 2026, closing a stake of 8,595 shares — an estimated $537K sold.

Aspiriant LLC first reported a position in FROG in Q4 2020 and held it in 21 quarters. The position peaked at $1.52M in Q1 2021. 326 funds tracked by Wall St. Rank hold FROG as of Q1 2026.

  • Aspiriant LLC reported no remaining JFrog position as of Q1 2026 after selling out during the quarter.
  • Aspiriant LLC sold 8,595 JFrog shares in Q1 2026, an estimated $537K.
  • Aspiriant LLC first reported a position in JFrog in Q4 2020 and held it in 21 quarters.
  • Aspiriant LLC's JFrog position peaked at $1.52M in Q1 2021.
  • 326 funds tracked by Wall St. Rank held JFrog as of Q1 2026.

Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.